SI1753764T1 - Derivati pirolopiridina - Google Patents
Derivati pirolopiridinaInfo
- Publication number
- SI1753764T1 SI1753764T1 SI200530497T SI200530497T SI1753764T1 SI 1753764 T1 SI1753764 T1 SI 1753764T1 SI 200530497 T SI200530497 T SI 200530497T SI 200530497 T SI200530497 T SI 200530497T SI 1753764 T1 SI1753764 T1 SI 1753764T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyrrolopyridine derivatives
- pyrrolopyridine
- derivatives
- Prior art date
Links
- 150000005255 pyrrolopyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0412908A GB0412908D0 (en) | 2004-06-09 | 2004-06-09 | Compounds |
GB0424950A GB0424950D0 (en) | 2004-11-11 | 2004-11-11 | Compounds |
EP05747418A EP1753764B1 (en) | 2004-06-09 | 2005-06-07 | Pyrrolopyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1753764T1 true SI1753764T1 (sl) | 2009-02-28 |
Family
ID=34969264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200530497T SI1753764T1 (sl) | 2004-06-09 | 2005-06-07 | Derivati pirolopiridina |
Country Status (26)
Country | Link |
---|---|
US (1) | US7589206B2 (sl) |
EP (1) | EP1753764B1 (sl) |
JP (1) | JP2008501758A (sl) |
KR (1) | KR20070034049A (sl) |
AR (1) | AR050158A1 (sl) |
AT (1) | ATE412651T1 (sl) |
AU (1) | AU2005251913A1 (sl) |
BR (1) | BRPI0511874A (sl) |
CA (1) | CA2569887A1 (sl) |
DE (1) | DE602005010698D1 (sl) |
DK (1) | DK1753764T3 (sl) |
ES (1) | ES2317244T3 (sl) |
HK (1) | HK1104175A1 (sl) |
HR (1) | HRP20090034T3 (sl) |
IL (1) | IL179603A0 (sl) |
MA (1) | MA28686B1 (sl) |
MX (1) | MXPA06014471A (sl) |
NO (1) | NO20070067L (sl) |
PE (1) | PE20060430A1 (sl) |
PL (1) | PL1753764T3 (sl) |
PT (1) | PT1753764E (sl) |
RU (1) | RU2006147278A (sl) |
SI (1) | SI1753764T1 (sl) |
TW (1) | TW200611695A (sl) |
UY (1) | UY28945A1 (sl) |
WO (1) | WO2005121140A1 (sl) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS20060035A (en) | 2003-07-22 | 2008-08-07 | Arena Pharmaceuticals Inc., | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto |
WO2005121140A1 (en) | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Pyrrolopyridine derivatives |
KR101764575B1 (ko) * | 2004-07-28 | 2017-08-03 | 다케다 야쿠힌 고교 가부시키가이샤 | 피롤로〔2,3-c〕피리딘 화합물, 그 제조 방법 및 용도 |
KR100958829B1 (ko) * | 2004-09-03 | 2010-05-25 | 주식회사유한양행 | 피롤로[2,3-c]피리딘 유도체 및 그의 제조방법 |
GB0516379D0 (en) * | 2005-08-09 | 2005-09-14 | Glaxo Group Ltd | Compounds |
MX2008001935A (es) * | 2005-08-09 | 2008-03-26 | Glaxo Group Ltd | Derivados de imidazopiridina como ligandos del receptor de canabinoides. |
EP2007707A1 (en) * | 2006-04-07 | 2008-12-31 | Boehringer Ingelheim International GmbH | Compounds which modulate the cb2 receptor |
EP2120950B1 (en) * | 2007-03-21 | 2012-07-04 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain |
GB0705803D0 (en) * | 2007-03-28 | 2007-05-02 | Glaxo Group Ltd | Novel compounds |
WO2009074607A1 (en) | 2007-12-12 | 2009-06-18 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
WO2009123714A2 (en) | 2008-04-02 | 2009-10-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
US8524727B2 (en) | 2009-03-30 | 2013-09-03 | Astellas Pharma Inc. | Pyrimidine compound |
TW201200518A (en) * | 2010-03-10 | 2012-01-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
EP2599774B1 (en) * | 2010-07-29 | 2016-07-06 | Astellas Pharma Inc. | Condensed pyridine compounds as cb2 cannabinoid receptor ligands |
US20150051299A1 (en) * | 2012-03-19 | 2015-02-19 | Ariel-University Research And Development Company, Ltd. | Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists |
ES2708998T3 (es) | 2013-06-26 | 2019-04-12 | Abbvie Inc | Carboxamidas primarias como inhibidores de btk |
CN109562085A (zh) | 2015-06-12 | 2019-04-02 | 阿速万科学有限责任公司 | 用于预防和治疗rem睡眠行为障碍的二芳基和芳基杂芳基脲衍生物 |
AU2016291673A1 (en) | 2015-07-15 | 2018-01-25 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease |
AU2019389025A1 (en) * | 2018-11-30 | 2021-06-17 | Takeda Pharmaceutical Company Limited | TYK2 inhibitors and uses thereof |
US11891394B1 (en) | 2023-09-06 | 2024-02-06 | King Faisal University | Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors |
US11858935B1 (en) | 2023-09-06 | 2024-01-02 | King Faisal University | Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3379404D1 (en) * | 1982-12-29 | 1989-04-20 | Kureha Chemical Ind Co Ltd | Cephalosporin derivatives |
CA2031927A1 (en) | 1989-12-27 | 1991-06-28 | Imperial Oil Limited | Method for improving the activity maintenance of a plasma initiator |
WO1991009598A1 (en) | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
US5112820A (en) * | 1990-03-05 | 1992-05-12 | Sterling Drug Inc. | Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof |
GB9109246D0 (en) | 1991-04-30 | 1991-06-19 | Ici Plc | Nitrogen derivatives |
DE4129603A1 (de) | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
TW263504B (sl) | 1991-10-03 | 1995-11-21 | Pfizer | |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5468757A (en) | 1994-01-31 | 1995-11-21 | Eli Lilly And Company | 6-azaindole thromboxane synthase inhibitors |
PL181323B1 (pl) | 1994-02-18 | 2001-07-31 | Boehringer Ingelheim Pharma | 2-heteroarylo-5,11-dihydro-6H-dipirydo[3,2-b:2’,3'-e][1,4] diazepinyi ich zastosowanie w zapobieganiu i leczeniu zakazen HIV PL PL PL |
GB9420521D0 (en) | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
US5589482A (en) | 1994-12-14 | 1996-12-31 | Pfizer Inc. | Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
JPH0920779A (ja) | 1995-05-01 | 1997-01-21 | Japan Tobacco Inc | 縮合ヘテロ5員環アゼピン化合物類及びその医薬用途 |
GB9610811D0 (en) | 1996-05-23 | 1996-07-31 | Pharmacia Spa | Combinatorial solid phase synthesis of a library of indole derivatives |
US6696448B2 (en) | 1996-06-05 | 2004-02-24 | Sugen, Inc. | 3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors |
EP0927167A1 (en) | 1996-08-14 | 1999-07-07 | Warner-Lambert Company | 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
WO1998050356A1 (en) | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
EP0931872B1 (de) | 1998-01-23 | 2003-04-09 | Voith Paper Patent GmbH | Verfahren zur Entfernung von feinen Verunreinigungen aus einer Faserstoffsuspension |
US6232320B1 (en) | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1117397A1 (en) | 1998-08-31 | 2001-07-25 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
GB9904995D0 (en) | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Substituted aza-oxindole derivatives |
EP1165076A4 (en) | 1999-03-10 | 2002-05-15 | Merck & Co Inc | 6-AZAINDOL COMPOUNDS AS GONADOLIBERINE'S ANTAGONISTS |
AU3868800A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
AU3514200A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
AU3868900A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
CA2367121A1 (en) | 1999-03-10 | 2000-09-14 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
AU3868500A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
EP1181296A1 (en) | 1999-06-03 | 2002-02-27 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
CA2390948A1 (en) | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
JP2004502642A (ja) | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
US20020061892A1 (en) | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
EP1132389A1 (en) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
KR20030024661A (ko) | 2000-04-28 | 2003-03-26 | 박스터 헬쓰케어 에스.에이. | 2-아실 인돌 유도체 및 항종양제로서의 이의 용도 |
BR0110420A (pt) | 2000-04-28 | 2003-07-01 | Acadia Pharm Inc | Agonistas muscarìnicos |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
MXPA03001420A (es) | 2000-08-14 | 2004-01-26 | Johnson & Johnson | Pirazoles sustituidos. |
US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
EP1315741A2 (en) | 2000-09-06 | 2003-06-04 | Ortho-McNeil Pharmaceutical, Inc. | A method for treating allergies |
MXPA03001962A (es) | 2000-09-06 | 2004-03-26 | Johnson & Johnson | Metodo para tratar alergias utilizando pirazoles sustituidos. |
AU2002211828A1 (en) | 2000-10-02 | 2002-04-15 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
IL156776A0 (en) | 2001-01-17 | 2004-02-08 | Amura Therapeutics Ltd | Inhibitors of cruzipain and other cysteine proteases |
JP4328527B2 (ja) | 2001-02-02 | 2009-09-09 | ブリストル−マイヤーズ スクイブ カンパニー | 置換アザインドールオキソアセチックピペラジン誘導体の組成物と抗ウイルス活性 |
US20030207910A1 (en) | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
EP1377549A1 (en) | 2001-03-12 | 2004-01-07 | Millennium Pharmaceuticals, Inc. | Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
EP1767525A1 (en) | 2001-04-09 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
EE200300546A (et) | 2001-05-14 | 2004-04-15 | Bristol-Myers Squibb Pharma Company | Asendatud pürasinoonid, püridiinid ja pürimidiinid kui kortikotropiini vabastava faktori ligandid |
AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
WO2003009852A1 (en) | 2001-07-24 | 2003-02-06 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
DE10143079A1 (de) | 2001-09-03 | 2003-05-15 | Zentaris Ag | Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel |
WO2003022214A2 (en) | 2001-09-06 | 2003-03-20 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
US6933303B2 (en) | 2001-10-19 | 2005-08-23 | Transtech Pharma, Inc. | Heteroaryl-fused nitrogen heterocycles as therapeutic agents |
DE10152306A1 (de) | 2001-10-26 | 2003-07-24 | Asta Medica Ag | 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften |
TW200301251A (en) | 2001-12-20 | 2003-07-01 | Wyeth Corp | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
DE60309852T2 (de) | 2002-03-27 | 2007-06-06 | Glaxo Group Ltd., Greenford | Chinolin- und aza-indolderivate und deren verwendung als 5-ht6 liganden |
EP1495016A2 (en) | 2002-04-09 | 2005-01-12 | Astex Technology Limited | Heterocyclic compounds and their use as modulators of p38 map kinase |
US20040063744A1 (en) | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
UA78999C2 (en) | 2002-06-04 | 2007-05-10 | Wyeth Corp | 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6 |
US6900206B2 (en) | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
TW200403243A (en) | 2002-07-18 | 2004-03-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
ATE323702T1 (de) | 2002-08-06 | 2006-05-15 | Astrazeneca Ab | Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität |
EP1534687B1 (en) | 2002-08-21 | 2006-09-27 | Glaxo Group Limited | 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
GB0222493D0 (en) | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
WO2004028481A2 (en) | 2002-09-30 | 2004-04-08 | Genelabs Technologies, Inc. | Nucleoside derivatives for treating hepatitis c virus infection |
FR2845388B1 (fr) | 2002-10-08 | 2004-11-12 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique |
CA2515571A1 (en) | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands |
US20040214856A1 (en) | 2003-04-23 | 2004-10-28 | Pfizer Inc | Cannabinoid receptor ligands and uses thereof |
WO2005121140A1 (en) | 2004-06-09 | 2005-12-22 | Glaxo Group Limited | Pyrrolopyridine derivatives |
-
2005
- 2005-06-07 WO PCT/EP2005/006182 patent/WO2005121140A1/en active Application Filing
- 2005-06-07 PL PL05747418T patent/PL1753764T3/pl unknown
- 2005-06-07 AR ARP050102327A patent/AR050158A1/es unknown
- 2005-06-07 DE DE602005010698T patent/DE602005010698D1/de active Active
- 2005-06-07 UY UY28945A patent/UY28945A1/es unknown
- 2005-06-07 AT AT05747418T patent/ATE412651T1/de not_active IP Right Cessation
- 2005-06-07 SI SI200530497T patent/SI1753764T1/sl unknown
- 2005-06-07 JP JP2007526300A patent/JP2008501758A/ja not_active Withdrawn
- 2005-06-07 BR BRPI0511874-3A patent/BRPI0511874A/pt not_active IP Right Cessation
- 2005-06-07 DK DK05747418T patent/DK1753764T3/da active
- 2005-06-07 ES ES05747418T patent/ES2317244T3/es active Active
- 2005-06-07 EP EP05747418A patent/EP1753764B1/en active Active
- 2005-06-07 KR KR1020077000449A patent/KR20070034049A/ko not_active Application Discontinuation
- 2005-06-07 TW TW094118669A patent/TW200611695A/zh unknown
- 2005-06-07 AU AU2005251913A patent/AU2005251913A1/en not_active Abandoned
- 2005-06-07 US US11/570,099 patent/US7589206B2/en not_active Expired - Fee Related
- 2005-06-07 MX MXPA06014471A patent/MXPA06014471A/es unknown
- 2005-06-07 PT PT05747418T patent/PT1753764E/pt unknown
- 2005-06-07 RU RU2006147278/04A patent/RU2006147278A/ru not_active Application Discontinuation
- 2005-06-07 PE PE2005000651A patent/PE20060430A1/es not_active Application Discontinuation
- 2005-06-07 CA CA002569887A patent/CA2569887A1/en not_active Abandoned
-
2006
- 2006-11-27 IL IL179603A patent/IL179603A0/en unknown
- 2006-12-28 MA MA29569A patent/MA28686B1/fr unknown
-
2007
- 2007-01-04 NO NO20070067A patent/NO20070067L/no not_active Application Discontinuation
- 2007-08-16 HK HK07108940.7A patent/HK1104175A1/xx not_active IP Right Cessation
-
2009
- 2009-01-20 HR HR20090034T patent/HRP20090034T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MA28686B1 (fr) | 2007-06-01 |
EP1753764B1 (en) | 2008-10-29 |
ATE412651T1 (de) | 2008-11-15 |
WO2005121140A1 (en) | 2005-12-22 |
DE602005010698D1 (de) | 2008-12-11 |
AR050158A1 (es) | 2006-10-04 |
AU2005251913A1 (en) | 2005-12-22 |
DK1753764T3 (da) | 2009-02-16 |
US7589206B2 (en) | 2009-09-15 |
ES2317244T3 (es) | 2009-04-16 |
MXPA06014471A (es) | 2007-03-21 |
PE20060430A1 (es) | 2006-05-25 |
TW200611695A (en) | 2006-04-16 |
CA2569887A1 (en) | 2005-12-22 |
BRPI0511874A (pt) | 2008-01-15 |
HK1104175A1 (en) | 2008-01-04 |
US20070219229A1 (en) | 2007-09-20 |
NO20070067L (no) | 2007-02-09 |
PL1753764T3 (pl) | 2009-04-30 |
IL179603A0 (en) | 2007-05-15 |
RU2006147278A (ru) | 2008-07-20 |
PT1753764E (pt) | 2009-01-28 |
UY28945A1 (es) | 2006-01-31 |
HRP20090034T3 (en) | 2009-03-31 |
JP2008501758A (ja) | 2008-01-24 |
KR20070034049A (ko) | 2007-03-27 |
EP1753764A1 (en) | 2007-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1104175A1 (en) | Pyrrolopyridine derivatives | |
TWI369356B (en) | Tetrahydropyridoindole derivatives | |
IL180481A0 (en) | Aryl-pyridine derivatives | |
ZA200610102B (en) | Pyrrazolo-pyrimidine derivatives | |
IL180331A0 (en) | 3-carbamoyl - 2 - pyridone derivative | |
AP2074A (en) | New 4-benzylidene-piperidin derivatives | |
EP1748048A4 (en) | IMIDAZOPYRIDINE COMPOUND | |
IL183140A0 (en) | Substituted benzoquinolizine derivatives | |
IL182585A0 (en) | Imidazo-benzodiazepine derivatives | |
HK1101638A1 (en) | New pyridothienopyrimidine derivatives | |
HK1100002A1 (en) | 4-phenyl-pyrimidine-2-carbonitrile derivatives | |
IL183141A0 (en) | New pyridothienopyrimidine derivatives | |
HK1100775A1 (en) | 4-Amino-5-cyanopyrimidine derivatives | |
GB0414272D0 (en) | OsK1 derivatives | |
IL178774A0 (en) | Imidazopyridine compound | |
IL182001A0 (en) | 2-acylaminothiazole derivatives | |
ZA200609864B (en) | Pyrrolopyridine derivatives | |
GB0422398D0 (en) | Pyridopyrimidine derivatives | |
GB0422397D0 (en) | 3-Cyano-Quinoline derivatives | |
GB0405905D0 (en) | Azaquinazoline derivatives |